Leenlife Pharma S.A.

Non-specialised wholesale trade

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-06-25
Share capital
100,000.00 PLN
Activity description

Leenlife Pharma is a company that offers a patented nutraceutical product called Omega3+6concept, which is designed to positively modulate physiological functions and improve health. Their products are aimed at enhancing heart health, mental well-being, and immunity. The company emphasizes the health benefits of their offerings, including improved skin appearance and overall well-being.

Registered address
ul. Gen. Juliana Filipowicza 2/7, 30-611 Kraków, Poland
Phone
Electronic delivery address
AE:PL-58575-49022-VEUBG-12

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 1077 days for 2019). 4 of 6 audited by a statutory auditor.

  • 2025not filed
  • 202407/11/2025
  • 202307/11/2025
  • 202222/12/2022
  • 202122/12/2022
  • 202022/12/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Non-specialised wholesale trade5,862 / 7,427
Top 79%
Division · Wholesale trade22,908 / 29,067
Top 79%
Voivodeship · Małopolskie31,081 / 46,048
Top 68%
Country · Poland338,499 / 496,474
Top 68%

Results vs industry

Revenue
This companyUSD 47.61kMedianUSD 637.17kAverageUSD 7.52m
Net profit
This companyUSD 10.92kMedianUSD 12.57kAverageUSD 216.92k
Operating costs
This companyUSD 10.31kMedianUSD 587.23kAverageUSD 7.20m
Assets
This companyUSD 4.38kMedianUSD 365.51kAverageUSD 3.43m

Offer

Websites

Authorized Representatives

Zbigniew Powierża age 58 – President of the Management Board

Manner of representation

1. In the case of a one-person management board, the President of the Management Board is authorised to make declarations of will and incur liabilities on behalf of the company. 2. In the case where the management board is multi-member, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, is authorised to make declarations of will and incur liabilities on behalf of the company.

Supervisory board

Karolina Stącel age 34 – Supervisory Board Member
Tadeusz Stanisław Zając age 78 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2013-07-02 to 2026-09-15.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jun 30, 2025Shareholders' meeting convened
Nov 24, 2016Commercial Companies Code notice
Nov 10, 2016Shareholders' meeting convened
Oct 19, 2016Commercial Companies Code notice
Sep 19, 2016Shareholders' meeting convened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
PRO Aktiv sp. z o.o.
Fitlabs sp. z o.o.
Next Trade Group sp. z o.o.
Pro-Noo-Biotics sp. z o.o.
Revital Nutrition sp. z o.o.
Holistic Poland sp. z o.o.
RESQ Lab sp. z o.o.
Carnomed sp. z o.o.
Leenvit Group sp. z o.o.
Mylabs sp. z o.o.

Change history

DateEvent
2015-06-17Address change
2015-06-17PKD change
2014-03-04Address change
2013-06-25Entered in the register

FAQ

Last updated: 2026-03-24